Scientists are close to a major breakthrough in organ transplantation. Researchers from Canada and China collaborated to develop the Universal Kideny, which is theoretically compatible with any blood ...

Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties.

After ten years of research, scientists have made a major step toward solving one of the biggest challenges in kidney transplants finding a perfect match between donor and recipient blood types.A team ...